| Literature DB >> 22705606 |
Hussam F Al Faleh1, Lukman Thalib, Khalid F AlHabib, Anhar Ullah, Khalid AlNemer, Shukri M AlSaif, Amir N Taraben, Asif Malik, Ahmed M Abuosa, Layth A Mimish, Ahmad Salah Hersia.
Abstract
BACKGROUND AND OBJECTIVES: It is often suggested that acute coronary syndrome (ACS) patients admitted during off-duty hours (OH) have a worse clinical outcome than those admitted during regular working hours (RH). Our objective was to compare the management and hospital outcomes of ACS patients admitted during OH with those admitted during RH. DESIGN ANDEntities:
Mesh:
Substances:
Year: 2012 PMID: 22705606 PMCID: PMC6081017 DOI: 10.5144/0256-4947.2012.366
Source DB: PubMed Journal: Ann Saudi Med ISSN: 0256-4947 Impact factor: 1.526
Baseline patient characteristics.
| Overall (N=2825) | Regular hours (n=1016) | Off hours (n=1809) | ||
|---|---|---|---|---|
|
| ||||
| Age (mean, SD) | 57.7 (13.2) | 57.9 (13.2) | 57.6 (13.3) | .573 |
| Males (%) | 2216 (78.4) | 802 (28.9) | 1414 (78.2) | .632 |
| Saudi (%) | 2197 (77.8) | 797 (77.8) | 1400 (77.4) | .518 |
| Diabetes mellitus (%) | 1603 (56.8) | 584 (57.5) | 1019 (56.4) | .566 |
| Hypertension (%) | 1591 (56.3) | 571 (56.2) | 1020 (56.4) | .870 |
| Smoking (%) | 953 (33.9) | 324 (31.8) | 629 (34.7) | .115 |
| Dyslipidemia (%) | 291 (25.9) | 105 (28.2) | 186 (24.7) | .456 |
| Waist circumference (median, IQR) | 98.0 (18) | 99 (19) | 98 (18) | .649 |
| BMI (median, IQR) | 27.7 (6.3) | 27.7 (6.2) | 27.7 (6.4) | .681 |
| Symptom to admission time (median, min) | 120 (173) | 137 (190) | 105 (165) | <.001 |
| History of coronary artery disease (%) | 482 (47.5) | 797 (44.1) | 1279 (45.3) | .075 |
| Prior PCI (%) | 456 (16.1) | 179 (17.6) | 277 (15.3) | .009 |
| Prior CABG (%) | 183 (6.5) | 65 (6.4) | 118 (6.5) | .092 |
| History of PAD (%) | 124 (4.4) | 363 (3.5) | 88 (4.9) | .277 |
| History of CVA (%) | 179 (6.3) | 56 (5.5) | 123 (6.8) | .092 |
| Creatinine, μmol/dl (median, IQR) | 92.0 (32) | 90.0 (26) | 92.0 (29) | .001 |
| Hemoglobin g/dL (median, IQR) | 14.0 (3) | 14 (2) | 14 (3) | .721 |
| FBS, μmol/dL (median, IQR) | 6.6 (4) | 6.6 (4) | 6.7 (4) | .516 |
| HR >100 bpm (%) | 417 (14.8) | 103 (10.1) | 314 (17.4) | <.001 |
| SBP ≤90 mm Hg (%) | 81 (2.9) | 30 (3.0) | 51 (2.8) | .631 |
| Heart failure (%) | 627 (22.3) | 193 (19.1) | 434 (24.0) | .002 |
| STEMI <12 hr (%) | 927 (81.4) | 309 (81.9) | 618 (81.1) | .441 |
| Anterior STEMI (%) | 623 (56.1) | 221 (59.8) | 402 (54.2) | .772 |
| ECG to admission time, min (median, IQR) | 14 (16.5) | 10.0 (16.0) | 10.0 (15.0) | .405 |
| LVEF <35% (%) | 881 (31.2) | 306 (30.1) | 575 (31.8) | .359 |
| 3V or LM coronary disease (%) | 621 (22) | 233 (22.9) | 388 (21.4) | .360 |
BMI: Body mass index; IQR: interquartile ranges; SD: standard deviation; PCI: percutaneous coronary intervention; CABG: coronary artery bypass grafting; PAD: peripheral arterial disease; CVA: cerebrovascular accidents; HR: heart rate; SBP: systolic blood pressure; STEMI: ST elevation myocardial infarction; ECG: electrocardiography; LVEF: left ventricular ejection fraction; 3V: three vessel; LM: Left main.
Proportions were out of the total STEMI patients.
Hospital therapies.
| Overall (N=2825) | Regular hours (n=1016) | Off hours (n=1809) | ||
|---|---|---|---|---|
|
| ||||
| Aspirin (%) | 2775 (98.5) | 991(97.9) | 1784 (98.8) | .075 |
| Clopidogrel (%) | 2458 (87.3) | 879 (86.9) | 1579 (87.5) | .635 |
| Beta-blockers (%) | 2369 (84.1) | 869 (85.9) | 1500 (83.1) | .050 |
| Statins (%) | 2722 (96.6) | 980 (96.8) | 1742 (96.5) | .592 |
| ACE I (%) | 2002 (71.0) | 727 (71.8) | 1275 (70.6) | .486 |
| ARB (%) | 179 (6.4) | 57 (5.6) | 122 (6.8) | .238 |
| Heparin (%) | 2544 (90.1) | 887 (87.5) | 1657 (91.6) | <.001 |
| GP 2b 3a inhibitors (%) | 838 (29.7) | 303 (29.9) | 535 (29.6) | .864 |
| Fibrinolytic use (%) | 653 (70.4) | 199 (64.4) | 454 (73.5) | .004 |
| ECG to admission time, min (median, IQR) | 14 (16.5) | 10.0 (16.0) | 10.0 (15.0) | .405 |
| DNT (median, IQR) | 54 (60) | 50.0 (52.5) | 54.5 (67.2) | .336 |
| DNT <30min (%) | 94 (14.4) | 26 (13.2) | 68 (15.0) | .553 |
| Fibrinolytic short fall (%) | 208 (14.4) | 81 (7.9) | 127 (7) | .352 |
| Primary PCI (%) | 158 (17) | 66 (21.4) | 92 (14.9) | .014 |
| DBT Median, min (IQR) | 110.5 (72.8) | 96 (49) | 122 (92) | .002 |
| DBT <90 min (%) | 46 (31.1) | 24 (39.3) | 22 (25.3) | .069 |
| Hospital length of stay, days (median, IQR) | 5 (5) | 5 (5) | 5 (5) | .802 |
ACEI: Angiotensin-converting enzyme inhibitor; ARB: Angiotensin receptor blocker; GP 2b 3a inhibitors: glycoprotein 2b 3a inhibitors; DNT: door to needle time; DBT: door to balloon time; Fibrinolytic short fall: eligible for fibrinolytic therapy but did not receive it; IQR: interquartile ranges; SD: standard deviation.
Proportions were out of the STEMI patients presenting within 12 hours of chest pain onset;
Proportions were out of STEMI patients receiving fibrinolytic therapy.
In-hospital outcomes.
| Outcome | Overall (N=2825) | Regular hours (n=1016) | Off hours (n=1809) | |
|---|---|---|---|---|
|
| ||||
| Overall death (%) | 92 (3.3) | 32 (3.2) | 60 (3.3) | .234 |
| Death in STEMI | 57 (5) | 17 (4.5) | 40 (5.2) | .590 |
| Overall re-infarction | 30 (1.1) | 11 (1.1) | 19 (1.1) | .935 |
| Major bleeding | 36 (1.3) | 17 (1.7) | 19 (1.1) | .157 |
| Stroke/TIA | 23 (0.8) | 9 (0.9) | 14 (0.8) | .751 |
| Heart failure | 273 (9.7) | 73 (7.2) | 200 (11.1) | <.001 |
| Cardiogenic shock | 125 (4.4) | 35 (3.4) | 90 (5.0) | .058 |
STEMI: ST elevation myocardial infarction; TIA: transient ischemic attacks.